TRETINOIN
BARR LABS INC · TRETINOIN
Open FDA's page for this record- Application number
- ANDA077684
- Sponsor name
- BARR LABS INC
- Submissions
- Submission type
- SUPPL
- Submission number
- 14
- Submission status
- AP
- Submission status date
- 20250224
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20070621
- Application docs
- ID
- 9076
- Url
- http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2007/077684s000ltr.pdf
- Date
- 20070705
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 3
- Submission status
- AP
- Submission status date
- 20090824
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Submission type
- SUPPL
- Submission number
- 15
- Submission status
- AP
- Submission status date
- 20250224
- Review priority
- STANDARD
- Submission class code
- LABELING
- Submission class code description
- Labeling
- Products
- Product number
- 001
- Reference drug
- No
- Brand name
- TRETINOIN
- Reference standard
- No
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Te code
- AB
- Active ingredients
- Name
- TRETINOIN
- Strength
- 10MG
